Natco Pharma looks to improve domestic revenues with more product launches

Turning its focus again to the domestic market, Hyderabad-based Natco Pharma Limited said in the near term it was planning to launch 8-10 branded generic products in India

Domestic market has contributed a third of Natco Pharma's revenues of Rs 22 billion in 2017-18, though slipped in sales for the first time.

Last year the company had launched 7 products, majority of them in Oncology space in which the company claims to have a market leading presence with a total portfolio of 30 products in India. Yet, domestic formulations' revenues declined 18 per cent to Rs 7.2 billion as compared to Rs